ANALYSIS OF PARA IV LAWSUITS. A recent study analyzed over 370 court rulings since the beginning of 2000 to 2009 to determine success rates. “The authors hypothesize that, based on the incentives of the Hatch-Waxman first-to-file structure, every (pharma) patented product would be challenged.””
”
http://lnkd.in/dc6W3aBhttp://lnkd.in/dbyhKdY